Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Growth Differentiation Factor 15 in Heart Failure: An Update
Kai C. Wollert, Tibor Kempf
Current Heart Failure Reports (2012) Vol. 9, Iss. 4, pp. 337-345
Closed Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Ramu Adela, S. Banerjee
Journal of Diabetes Research (2015) Vol. 2015, pp. 1-14
Open Access | Times Cited: 406
Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation
Lars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
Circulation (2014) Vol. 130, Iss. 21, pp. 1847-1858
Open Access | Times Cited: 272
The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
Klaus Unsicker, Björn Spittau, Kerstin Krieglstein
Cytokine & Growth Factor Reviews (2013) Vol. 24, Iss. 4, pp. 373-384
Closed Access | Times Cited: 248
Novel biomarkers for cardiovascular risk prediction.
Juan Wang, Guo-Juan Tan, Lina Han, et al.
PubMed (2017) Vol. 14, Iss. 2, pp. 135-150
Closed Access | Times Cited: 232
State of the Art: Newer biomarkers in heart failure
Rudolf A. de Boer, Lori B. Daniels, Alan S. Maisel, et al.
European Journal of Heart Failure (2015) Vol. 17, Iss. 6, pp. 559-569
Open Access | Times Cited: 178
Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?
Jill Corre, Benjamin Hébraud, Philippe Bourin
Stem Cells Translational Medicine (2013) Vol. 2, Iss. 12, pp. 946-952
Open Access | Times Cited: 178
Anti‐inflammatory cytokines and risk of type 2 diabetes
Christian Herder, Maren Carstensen, D. Margriet Ouwens
Diabetes Obesity and Metabolism (2013) Vol. 15, Iss. s3, pp. 39-50
Open Access | Times Cited: 161
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial
Tibor Kempf, Anja Guba‐Quint, Jarl Torgerson, et al.
European Journal of Endocrinology (2012) Vol. 167, Iss. 5, pp. 671-678
Open Access | Times Cited: 153
Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction
Michelle Chan, Rajalakshmi Santhanakrishnan, Jenny Chong, et al.
European Journal of Heart Failure (2015) Vol. 18, Iss. 1, pp. 81-88
Open Access | Times Cited: 151
GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
Lars Wallentin, Björn Zethelius, Lars Berglund, et al.
PLoS ONE (2013) Vol. 8, Iss. 12, pp. e78797-e78797
Open Access | Times Cited: 115
Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases
Thomas Mueller, Isabella Leitner, Margot Egger, et al.
Clinica Chimica Acta (2015) Vol. 445, pp. 155-160
Open Access | Times Cited: 106
GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD
Courtney Tuegel, Ronit Katz, Mariam Alam, et al.
American Journal of Kidney Diseases (2018) Vol. 72, Iss. 4, pp. 519-528
Open Access | Times Cited: 102
Emerging biomarkers for the detection of cardiovascular diseases
Sreenu Thupakula, Shiva Shankar Reddy Nimmala, Haritha Ravula, et al.
The Egyptian Heart Journal (2022) Vol. 74, Iss. 1
Open Access | Times Cited: 39
A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies
Vasudeva Reddy Netala, Sireesh Kumar Teertam, Huizhen Li, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1471-1471
Open Access | Times Cited: 13
GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells
Nils Nickel, Danny Jonigk, Tibor Kempf, et al.
Respiratory Research (2011) Vol. 12, Iss. 1
Open Access | Times Cited: 88
Growth Differentiation Factor-15 Deficiency Augments Inflammatory Response and Exacerbates Septic Heart and Renal Injury Induced by Lipopolysaccharide
Palida Abulizi, Neruja Loganathan, Duo Zhao, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 79
Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction
Yasuhiro Izumiya, Shinsuke Hanatani, Yuichi Kimura, et al.
Canadian Journal of Cardiology (2013) Vol. 30, Iss. 3, pp. 338-344
Closed Access | Times Cited: 76
GDF15 is a heart‐derived hormone that regulates body growth
Ting Wang, Jian Liu, Caitlin McDonald, et al.
EMBO Molecular Medicine (2017) Vol. 9, Iss. 8, pp. 1150-1164
Open Access | Times Cited: 76
Multibiomarker analysis in patients with acute myocardial infarction
Christiana Schernthaner, Michael Lichtenauer, Bernhard Wernly, et al.
European Journal of Clinical Investigation (2017) Vol. 47, Iss. 9, pp. 638-648
Closed Access | Times Cited: 71
GDF15 contributes to radiation-induced senescence through the ROS-mediated p16 pathway in human endothelial cells
Hyejin Park, Chun‐Ho Kim, Jae‐Hoon Jeong, et al.
Oncotarget (2016) Vol. 7, Iss. 9, pp. 9634-9644
Open Access | Times Cited: 70
Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction
M Boulogne, Malha Sadoune, J-M. Launay, et al.
International Journal of Cardiology (2016) Vol. 226, pp. 53-59
Closed Access | Times Cited: 66
Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study
Nisha Bansal, Leila R. Zelnick, Alan S. Go, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 21
Open Access | Times Cited: 66
Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player
Marian Wesseling, Julius H.C. de Poel, Saskia C.A. de Jager
ESC Heart Failure (2020) Vol. 7, Iss. 4, pp. 1488-1501
Open Access | Times Cited: 66
Biomarkers in Heart Failure with Preserved Ejection Fraction
Antoni Bayés‐Genís, Germán Cediel, Mar Domingo, et al.
Cardiac failure review (2022) Vol. 8
Open Access | Times Cited: 34
Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure Management
Khalid Sawalha, Nicholas B. Norgard, Betty M. Drees, et al.
Current Heart Failure Reports (2023) Vol. 20, Iss. 4, pp. 287-299
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top